Sorry, you need to enable JavaScript to visit this website.
Skip to main content

Top Menu

  • Indication Indication

    VYNDAMAX is a prescription medicine used to treat adults with the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) to reduce death and hospitalization related to heart problems. It is not known if VYNDAMAX is safe and effective in children.

  • Important Safety Information
  • Patient Information
  • Full Prescribing Information
  • For Healthcare Professionals

Main Menu

  • Home
  • About ATTR-CM
    • What is ATTR-CM?
    • The impact of ATTR-CM
    • Taking action
  • Why VYNDAMAX?
    • How VYNDAMAX may help
    • How VYNDAMAX works
    • Talking to your doctor
  • Taking VYNDAMAX
    • VYNDAMAX dosing & side effects
    • Starting on VYNDAMAX
    • Staying on VYNDAMAX
  • Support and Resources
    • Financial assistance
    • Hereditary ATTR-CM resources
    • Caregiver support
    • Downloadable brochures
    • Advocacy groups
  • Sign Up
  • Indication
  • Important Safety Information
  • Patient Information
  • Full Prescribing Information
  • For Healthcare Professionals

Main Menu

  • Financial assistance
  • Hereditary ATTR-CM resources
  • Caregiver support
  • Downloadable brochures
  • Advocacy groups
Patient smiling while gardening

Hereditary ATTR-CM resources

If you have hereditary ATTR-CM, it’s important your relatives consider genetic testing and counseling.

Patient smiling while gardening

Hereditary ATTR-CM resources

If you have hereditary ATTR-CM, it’s important your relatives consider genetic testing and counseling.

Main Menu

  • Financial assistance
  • Hereditary ATTR-CM resources
  • Caregiver support
  • Downloadable brochures
  • Advocacy groups

If you’ve been diagnosed with hereditary ATTR-CM, your loved ones may also be at risk

It is important for patients with hereditary ATTR-CM to encourage their family members to get genetic testing and counseling. This can be important for not only you as the patient but also close relatives, like siblings and adult children. Not all individuals with the V122I mutation develop symptoms of hereditary ATTR-CM.

Genetic testing:

  • will help confirm or rule out the hereditary form of ATTR-CM
  • may help identify if family members are at risk, because the TTR mutation can be passed down
  • is typically performed using blood or saliva samples

Genetic counseling may be available to help those diagnosed with hereditary ATTR-CM (and their families) to understand test results and potential next steps to take.

Genetic testing and counseling may be available to eligible patients and family members at no cost.

VYNDAMAX may help those diagnosed with hereditary ATTR-CM

Among the patients studied in the clinical trials, 24% had hereditary ATTR-CM, and 14% were Black.

Additionally, VYNDAMAX is offered as a single capsule you can take from the comfort of your home as prescribed by your doctor.

VyndaCares

Get to the heart of what to know about ATTR-CM and VYNDAMAX

Sign up to learn more about how VYNDAMAX may help you manage your disease.

Sign up

Want to learn about financial-assistance options?

Learn how we can help.

Financial assistance
Patient on the phone
Patient on the phone

Want to learn about financial-assistance options?

Learn how we can help.

Financial assistance

IMPORTANT SAFETY INFORMATION AND INDICATION

View More
Before taking VYNDAMAX, tell your healthcare provider about all your medical conditions, including if you:
  • have liver problems.
  • are pregnant or plan to become pregnant.
  • are breastfeeding or plan to breastfeed.
Tell your healthcare provider about all the medicines you take including any prescription or over‑the‑counter medicines, vitamins, and herbal supplements.
There were no known side effects that happened during treatment with VYNDAMAX.
Indication
VYNDAMAX is a prescription medicine used to treat adults with the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) to reduce death and hospitalization related to heart problems. It is not known if VYNDAMAX is safe and effective in children.
 

IMPORTANT SAFETY INFORMATION AND INDICATION

Before taking VYNDAMAX, tell your healthcare provider about all your medical conditions, including if you:
  • have liver problems.
  • are pregnant or plan to become pregnant.
  • are breastfeeding or plan to breastfeed.
Tell your healthcare provider about all the medicines you take including any prescription or over‑the‑counter medicines, vitamins, and herbal supplements.
There were no known side effects that happened during treatment with VYNDAMAX.
Indication
VYNDAMAX is a prescription medicine used to treat adults with the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) to reduce death and hospitalization related to heart problems. It is not known if VYNDAMAX is safe and effective in children.
 
logo
Report Adverse Events Terms of Use Privacy Policy Contact Us About Pfizer Site Map
Patients should always ask their doctors for medical advice about adverse events.
You are encouraged to report adverse events related to Pfizer products by calling 1-800-438-1985 (U.S. only). If you prefer, you may contact the U.S. Food and Drug Administration (FDA) directly. Visit www.fda.gov/MedWatch or call 1-800-FDA-1088.
This site is intended only for U.S. residents. The products discussed in this site may have different product labeling in different countries. The information provided is for educational purposes only and is not intended to replace discussions with a healthcare provider.
© 2022 Pfizer Inc. All rights reserved.
August 2022 PP-VDM-USA-0967

IMPORTANT SAFETY INFORMATION AND INDICATION

View More
Before taking VYNDAMAX, tell your healthcare provider about all your medical conditions, including if you:
  • have liver problems.
  • are pregnant or plan to become pregnant.
  • are breastfeeding or plan to breastfeed.
Tell your healthcare provider about all the medicines you take including any prescription or over‑the‑counter medicines, vitamins, and herbal supplements.
There were no known side effects that happened during treatment with VYNDAMAX.
Indication
VYNDAMAX is a prescription medicine used to treat adults with the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) to reduce death and hospitalization related to heart problems. It is not known if VYNDAMAX is safe and effective in children.

You are now leaving VYNDAMAX.com.

Links to other websites are provided as a convenience to the viewer. Pfizer accepts no responsibility for the content of linked sites.

You are now leaving VYNDAMAX.com.

The information provided in this website is intended only for healthcare professionals in the United States.

Indication

VYNDAMAX is a prescription medicine used to treat adults with the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) to reduce death and hospitalization related to heart problems. It is not known if VYNDAMAX is safe and effective in children.